Cite
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis.
MLA
Manthey, Carl L., et al. “The CSF-1-Receptor Inhibitor, JNJ-40346527 (PRV-6527), Reduced Inflammatory Macrophage Recruitment to the Intestinal Mucosa and Suppressed Murine T Cell Mediated Colitis.” PLoS ONE, vol. 14, no. 11, Nov. 2019, pp. 1–23. EBSCOhost, https://doi.org/10.1371/journal.pone.0223918.
APA
Manthey, C. L., Moore, B. A., Chen, Y., Loza, M. J., Yao, X., Liu, H., Belkowski, S. M., Raymond-Parks, H., Dunford, P. J., Leon, F., Towne, J. E., & Plevy, S. E. (2019). The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis. PLoS ONE, 14(11), 1–23. https://doi.org/10.1371/journal.pone.0223918
Chicago
Manthey, Carl L., Beverley A. Moore, Yanqing Chen, Matthew J. Loza, Xiang Yao, Hao Liu, Stanley M. Belkowski, et al. 2019. “The CSF-1-Receptor Inhibitor, JNJ-40346527 (PRV-6527), Reduced Inflammatory Macrophage Recruitment to the Intestinal Mucosa and Suppressed Murine T Cell Mediated Colitis.” PLoS ONE 14 (11): 1–23. doi:10.1371/journal.pone.0223918.